|
Human Antibody Therapeutics for Viral Disease. t$ E% }4 U6 d: }, _6 X
. ^7 b8 Z* S4 r
Editors: Scott K. Dessain MD, PhD
0 ~: I2 ^! n m5 W1 O6 C1 J6 i1 FISBN: 978-3-540-72144-4 (Print) 978-3-540-72146-8 (Online)
- ]0 [5 r) v. @7 Z1 Q
6 `# B4 ~# t" k+ [/ K- O- }* |+ b) K
7 M/ z" f0 [8 d% t
Chapter7 ?! P( d' B) C) M
Pages 1-38
4 N6 F6 ^! `8 P# O4 j1 tTherapeutic Control of Hepatitis C Virus: The Role of Neutralizing Monoclonal Antibodies1 ?! q% l) {! ^# {0 K# ^
K. Machida, Z. Y. Keck, M. M. C. Lai, J. K. Ball, A. H. Patel, S. K. H. Foung' q N3 ]2 t+ R
# p6 [, c% T2 r" @8 p! D& `9 V( jChapter
+ s1 Y1 X# p4 ~5 LPages 39-66
! G7 c( ]/ }1 I# h) H1 Q; T0 X' ]Antibodies for HIV Treatment and Prevention: Window of Opportunity?
+ J2 n) y1 G7 \% v; DM. Huber, W. C. Olson, A. Trkola6 q1 x# Q* b: R7 m
# K& L6 Z- o) S" f0 CChapter
) j+ [( a7 N3 vPages 67-101
; ?2 u2 q1 s7 p. \& fHuman Monoclonal Antibody and Vaccine Approaches to Prevent Human Rabies
A% E- h6 ?3 p# N6 B* P9 S' ?8 OT. Nagarajan, Charles E. Rupprecht, Scott K. Dessain MD, PhD, P. N. Rangarajan…
' g) K4 \5 q7 F- K- j* r) X9 I- b" N, \
) w) G8 K J9 }$ _5 K. e4 _, {Chapter9 d7 y2 |7 Q7 @2 c
Pages 103-123( u7 V3 i) s0 [4 x
Immunoprophylaxis of RSV Infection: Advancing from RSV-IGIV to Palivizumab and Motavizumab
2 @5 I/ Z- E5 ?8 M( J- k ^, PH. Wu, D. S. Pfarr, G. A. Losonsky, P. A. Kiener
! V9 n" T+ u- h& B9 [
% x, W+ _4 W5 IChapter
* E" h3 J' G; ePages 125-153
: d! C* l3 {, e, W& v( t: OThe Molecular Basis of Antibody Protection Against West Nile Virus
7 V& v* E- F, q% |1 [M. S. Diamond, E. Mehlhop T, s/ ^" h. l+ W. w1 z
0 |+ _: D# A, s% D& Z0 L
Chapter0 d) ~! s1 `4 M
Pages 155-183
@8 P4 W- t9 w/ F+ H2 OExploring the Native Human Antibody Repertoire to Create Antiviral Therapeutics7 m! y |0 X8 ]% U! `1 T
Scott K. Dessain MD, PhD, S. P. Adekar, J. D. Berry9 _" {' P N7 b" x& i
% K o: U% j0 S4 `$ I9 D" ]* t+ b. }% I8 G5 w! q' o
下载地址:# p2 @* c) d. k1 ^ L. r# d
( m# z! Y8 Z: [! L# o& n% o3 P' |6 @# u( l3 r& E9 w* ?# d
|
本帖子中包含更多资源
您需要 登录 才可以下载或查看,没有帐号?立即注册
x
评分
-
查看全部评分
|